185 related articles for article (PubMed ID: 24871162)
1. One-pot synthesis of vinca alkaloids-phomopsin hybrids.
Gherbovet O; Coderch C; García Alvarez MC; Bignon J; Thoret S; Guéritte F; Gago F; Roussi F
J Med Chem; 2014 Jun; 57(12):5470-6. PubMed ID: 24871162
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of vinca alkaloids and phomopsin hybrids.
Ngo QA; Roussi F; Cormier A; Thoret S; Knossow M; Guénard D; Guéritte F
J Med Chem; 2009 Jan; 52(1):134-42. PubMed ID: 19072542
[TBL] [Abstract][Full Text] [Related]
3. Elaboration of simplified vinca alkaloids and phomopsin hybrids.
Ngo QA; Roussi F; Thoret S; Guéritte F
Chem Biol Drug Des; 2010 Mar; 75(3):284-94. PubMed ID: 20659111
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of C-13' substituted 7'-homo-anhydrovinblastine derivatives.
Gherbovet O; La Spisa F; Thoret S; Alvarez MCG; Levaique H; Bignon J; Roussi F
Bioorg Med Chem Lett; 2015 Apr; 25(8):1771-1773. PubMed ID: 25804719
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of hybrid molecules targeting the vinca domain of tubulin.
Gherbovet O; Sánchez-Murcia PA; García Alvarez MC; Bignon J; Thoret S; Gago F; Roussi F
Org Biomol Chem; 2015 Mar; 13(10):3144-54. PubMed ID: 25634805
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of a new series of highly functionalized 7'-homo-anhydrovinblastine derivatives.
Gherbovet O; Coderch C; García Alvarez MC; Bignon J; Thoret S; Martin MT; Guéritte F; Gago F; Roussi F
J Med Chem; 2013 Aug; 56(15):6088-100. PubMed ID: 23822556
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationship studies of cytotoxic anhydrovinblastine amide derivatives.
Shao Y; Zhang HK; Ding H; Quan HT; Lou LG; Hu LH
J Nat Prod; 2009 Jun; 72(6):1170-7. PubMed ID: 19499938
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of tubulin polymerization: synthesis and biological evaluation of hybrids of vindoline, anhydrovinblastine and vinorelbine with thiocolchicine, podophyllotoxin and baccatin III.
Passarella D; Giardini A; Peretto B; Fontana G; Sacchetti A; Silvani A; Ronchi C; Cappelletti G; Cartelli D; Borlak J; Danieli B
Bioorg Med Chem; 2008 Jun; 16(11):6269-85. PubMed ID: 18468444
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationship studies of cytotoxic ester and ether anhydrovinblastine derivatives.
Zhang HK; Shao Y; Ding H; Hu LH
J Nat Prod; 2008 Oct; 71(10):1669-76. PubMed ID: 18771244
[TBL] [Abstract][Full Text] [Related]
10. Theoretical insight into the structural mechanism for the binding of vinblastine with tubulin.
Chi S; Xie W; Zhang J; Xu S
J Biomol Struct Dyn; 2015; 33(10):2234-54. PubMed ID: 25588192
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological evaluation and molecular docking studies of resveratrol derivatives possessing curcumin moiety as potent antitubulin agents.
Ruan BF; Lu X; Li TT; Tang JF; Wei Y; Wang XL; Zheng SL; Yao RS; Zhu HL
Bioorg Med Chem; 2012 Jan; 20(2):1113-21. PubMed ID: 22189271
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of C-12' substituted vinflunine derivatives.
Lei XS; Yu XD; Yin L; Liu ZH; Tang PC
Bioorg Med Chem Lett; 2008 Aug; 18(16):4602-5. PubMed ID: 18653334
[TBL] [Abstract][Full Text] [Related]
13. The synthesis of Navelbine prototype of a new series of vinblastine derivatives.
Potier P
Semin Oncol; 1989 Apr; 16(2 Suppl 4):2-4. PubMed ID: 2540531
[No Abstract] [Full Text] [Related]
14. Structural plasticity of tubulin assembly probed by vinca-domain ligands.
Ranaivoson FM; Gigant B; Berritt S; Joullié M; Knossow M
Acta Crystallogr D Biol Crystallogr; 2012 Aug; 68(Pt 8):927-34. PubMed ID: 22868758
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of macrocyclic bisbibenzyl derivatives and their anticancer effects as anti-tubulin agents.
Jiang J; Sun B; Wang YY; Cui M; Zhang L; Cui CZ; Wang YF; Liu XG; Lou HX
Bioorg Med Chem; 2012 Apr; 20(7):2382-91. PubMed ID: 22365913
[TBL] [Abstract][Full Text] [Related]
16. The high-resolution X-ray structure of vinca-domain inhibitors of microtubules provides a rational approach for drug design.
Chengyong W; Jinghong X; Yanyan W; Qing-Jie X; Lingling M; Yuyan L; Hai C; Qian L; Quan Z; Bo S; Yuxi W
FEBS Lett; 2021 Jan; 595(2):195-205. PubMed ID: 33220079
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of 1-phenyl-1,2,3,4-dihydroisoquinoline compounds as tubulin polymerization inhibitors.
Zheng CH; Chen J; Liu J; Zhou XT; Liu N; Shi D; Huang JJ; Lv JG; Zhu J; Zhou YJ
Arch Pharm (Weinheim); 2012 Jun; 345(6):454-62. PubMed ID: 22415658
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, biological evaluation and molecular modeling of 1,3,4-oxadiazoline analogs of combretastatin-A4 as novel antitubulin agents.
Hu Y; Lu X; Chen K; Yan R; Li QS; Zhu HL
Bioorg Med Chem; 2012 Jan; 20(2):903-9. PubMed ID: 22192936
[TBL] [Abstract][Full Text] [Related]
19. 2-amino-3,4,5-trimethoxybenzophenones as potent tubulin polymerization inhibitors.
Chuang HY; Chang JY; Lai MJ; Kuo CC; Lee HY; Hsieh HP; Chen YJ; Chen LT; Pan WY; Liou JP
ChemMedChem; 2011 Mar; 6(3):450-6. PubMed ID: 21360819
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of 2,4,5-substituted pyrimidines as a new class of tubulin polymerization inhibitors.
Xie F; Zhao H; Li D; Chen H; Quan H; Shi X; Lou L; Hu Y
J Med Chem; 2011 May; 54(9):3200-5. PubMed ID: 21480626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
